MetaVia MTVA 深 滬
等待開盤 08-21 09:30:00 美东时间
1.44
-0.030
-2.04%
華盛通- 最 高1.47
- 今 開1.47
- 成交量 4.22万股
- 最 低 1.43
- 昨 收 1.47
- 總市值 948.69万
- 52周最高 19.0289
- 市盈率 靜 --
- 換手率 0.64%
- 52周最低 0.9661
- 委 比 99.89%
- 總股本 658.81万
- 歷史最高 1527900.00
- 量 比 0.49
- 振 幅 2.72%
- 歷史最低 0.9661
- 每 手 1
- 風險率 3.92%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多MetaVia Q2 EPS $(0.90) Misses $(0.82) Estimate
MetaVia (NASDAQ:MTVA) reported quarterly losses of $(0.90) per share which missed the analyst consensus estimate of $(0.82) by 9.76 percent. This is a 68.53 percent increase over losses of $(2.86) per share from the same period last year.
08-07 06:10
美股大行评级 | 潜在涨幅98.68%！DA Davidson上调Almonty Industries目标价至33美元，维持"买入"评级
今日重点评级关注：DA Davidson：维持Almonty Industries"买入"评级，目标价从25美元升至33美元；Stifel：维持Nurix Therapeutics"买入"评级，目标价从34美元升至40美元
07-13 10:13
MetaVia Says All Enrolled Active Patients In Part 3 Of Its Phase 1 Clinical Trial Evaluating DA-1726 For Obesity Treatment Completed Dose Titration, Now Receiving Highest Target Doses In Both Study Cohorts
All Active Patients in Both Cohorts Have Successfully Reached Highest Target Doses of 48 mg and 64 mg Topline Data Remains on Track for Fourth Quarter 2026 CAMBRIDGE, Mass., July 9, 2026 /PRNewswire/ -- MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardio...
07-09 20:36
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Bio Green Med Solution (NASDAQ:BGMS) stock increased by 180.2% to $2.9...
06-05 20:05
Why Solidion Technology Shares Are Rallying Over 50%; Here Are 20 Stocks Moving Premarket
Solidion Technology, Inc. (NASDAQ: STI) rose 50.55% in pre-market trading on Friday after announcing their extreme-climate battery technology.
06-05 18:03
MetaVia To Present Data On Obesity, Metabolic Therapies At Emerging Growth Conference
MetaVia Inc. (NASDAQ:MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that Hyung Heon Kim, President and Chief Executive Officer and Marshall H. Woodworth,
06-04 20:50
MetaVia Highlights New Phase 1 Data On DA-1726, Dual Oxyntomodulin Analog Agonist Targeting GLP1R And GCGR, In Late-Breaking Poster Presentation At EASL 2026
48 mg Cohort Achieved Up to 9.1% Mean Body Weight Reduction at Day 54 Without Evidence of PlateauExploratory FibroScan Assessments Demonstrated Early Liver-Related ImprovementsOngoing Phase 1 Part 3a/3b Titration Studies
05-27 20:37
Why MetaVia Stock Is Falling On Thursday?
MetaVia Inc. (NASDAQ: MTVA) shares drop over 10% on Thursday due to profit-taking despite announcing peer-reviewed data supporting its anti-fibrotic MASH drug candidate.
05-22 02:30
Why Agilysys Shares Are Trading Higher By Over 15%; Here Are 20 Stocks Moving Premarket
Agilysys Inc (AGYS) shares rose in pre-market trading after reporting better-than-expected financial results and issuing positive sales guidance. Other notable gainers and losers in pre-market trading include AMST, HAO, MTVA, ONCO, SDA, PIII, VRAX, PURR, BKKT, WOK, BTM, and UBXG.
05-19 16:47
美股大行评级 | 花旗上调英特尔目标价至130美元；大摩上调英伟达目标价至285美元；National 、Yesway获多家大行首予买入评级
今日重点评级关注：TD Cowen：维持Strive"买入"评级，目标价从28美元升至30美元；蒙特利尔银行：维持KinderCare Learning"跑赢大市"评级，目标价从4美元升至6美元
05-19 10:55
